TRV vs. MRK

Last updated Apr 1, 2026

Compare and contrast key facts about The Travelers Companies, Inc. (TRV) and Merck & Co., Inc. (MRK).

Performance

TRV vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Travelers Companies, Inc. (TRV) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

TRV vs. MRK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TRV The Travelers Companies, Inc.	0.92%	22.38%	28.76%	3.93%	22.42%	13.96%	5.31%	17.00%	-9.64%	13.36%
MRK Merck & Co., Inc.	15.13%	9.79%	-6.26%	1.01%	49.42%	1.75%	-7.20%	22.27%	39.95%	-1.49%

Fundamentals

EPS TRV : $25.72 MRK : $7.30
PE Ratio TRV : 11.34 MRK : 16.47
PEG Ratio TRV : 0.47 MRK : 0.01
PS Ratio TRV : 1.38 MRK : 4.63
Total Revenue (TTM) TRV : $48.41B MRK : $65.01B
Gross Profit (TTM) TRV : $15.60B MRK : $52.98B
EBITDA (TTM) TRV : $10.06B MRK : $28.80B

Returns By Period

In the year-to-date period, TRV achieves a 0.92% return, which is significantly lower than MRK's 15.13% return. Both investments have delivered pretty close results over the past 10 years, with TRV having a 11.93% annualized return and MRK not far ahead at 12.31%.

TRV

• 1D: -0.05%
• 1M: -5.15%
• YTD: 0.92%
• 6M: 5.26%
• 1Y: 12.04%
• 3Y*: 21.61%
• 5Y*: 16.40%
• 10Y*: 11.93%

MRK

• 1D: 1.85%
• 1M: -2.13%
• YTD: 15.13%
• 6M: 45.62%
• 1Y: 38.88%
• 3Y*: 7.42%
• 5Y*: 13.86%
• 10Y*: 12.31%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TRV vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRV

TRV Risk / Return Rank: 62
TRV Sharpe Ratio Rank: 62
TRV Sortino Ratio Rank: 54
TRV Omega Ratio Rank: 54
TRV Calmar Ratio Rank: 67
TRV Martin Ratio Rank: 71

MRK

MRK Risk / Return Rank: 79
MRK Sharpe Ratio Rank: 82
MRK Sortino Ratio Rank: 78
MRK Omega Ratio Rank: 76
MRK Calmar Ratio Rank: 80
MRK Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TRV vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Travelers Companies, Inc. (TRV) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TRV	MRK	Difference
Sharpe ratio Return per unit of total volatility	0.57	1.34	-0.78
Sortino ratio Return per unit of downside risk	0.91	1.96	-1.05
Omega ratio Gain probability vs. loss probability	1.12	1.25	-0.13
Calmar ratio Return relative to maximum drawdown	1.14	2.19	-1.05
Martin ratio Return relative to average drawdown	3.45	5.34	-1.88
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TRV vs. MRK - Sharpe Ratio Comparison

The current TRV Sharpe Ratio is 0.57, which is lower than the MRK Sharpe Ratio of 1.34. The chart below compares the historical Sharpe Ratios of TRV and MRK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TRV	MRK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.57	1.34	-0.78
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.76	0.60	+0.16
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.49	0.54	-0.05
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.49	-0.10

Correlation

The correlation between TRV and MRK is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TRV vs. MRK - Dividend Comparison

TRV's dividend yield for the trailing twelve months is around 1.51%, less than MRK's 2.76% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
TRV The Travelers Companies, Inc.	1.51%	1.50%	1.72%	2.06%	1.96%	2.23%	2.40%	2.36%	2.53%	2.09%	2.14%	2.11%
MRK Merck & Co., Inc.	2.76%	3.12%	3.14%	2.72%	2.52%	3.41%	3.03%	2.48%	2.60%	3.36%	3.14%	3.43%

Drawdowns

TRV vs. MRK - Drawdown Comparison

The maximum TRV drawdown since its inception was -55.11%, smaller than the maximum MRK drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for TRV and MRK.

Drawdown Indicators

	TRV	MRK	Difference
Max Drawdown Largest peak-to-trough decline	-55.11%	-68.61%	+13.50%
Max Drawdown (1Y) Largest decline over 1 year	-11.61%	-15.67%	+4.06%
Max Drawdown (5Y) Largest decline over 5 years	-18.90%	-43.44%	+24.54%
Max Drawdown (10Y) Largest decline over 10 years	-46.28%	-43.44%	-2.84%
Current Drawdown Current decline from peak	-6.18%	-4.04%	-2.14%
Average Drawdown Average peak-to-trough decline	-11.16%	-18.89%	+7.73%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.82%	7.44%	-3.62%

Volatility

TRV vs. MRK - Volatility Comparison

The current volatility for The Travelers Companies, Inc. (TRV) is 4.82%, while Merck & Co., Inc. (MRK) has a volatility of 5.85%. This indicates that TRV experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TRV	MRK	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.82%	5.85%	-1.03%
Volatility (6M) Calculated over the trailing 6-month period	12.68%	19.79%	-7.11%
Volatility (1Y) Calculated over the trailing 1-year period	21.35%	29.08%	-7.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.83%	23.30%	-1.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.39%	22.68%	+1.71%

Financials

TRV vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between The Travelers Companies, Inc. and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

TRV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, The Travelers Companies, Inc. reported a gross profit of 5.88B and revenue of 12.47B. Therefore, the gross margin over that period was 47.1%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Merck & Co., Inc. reported a gross profit of 15.20B and revenue of 16.40B. Therefore, the gross margin over that period was 92.7%.

TRV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, The Travelers Companies, Inc. reported an operating income of 2.46B and revenue of 12.47B, resulting in an operating margin of 19.7%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Merck & Co., Inc. reported an operating income of 8.74B and revenue of 16.40B, resulting in an operating margin of 53.3%.

TRV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, The Travelers Companies, Inc. reported a net income of 1.89B and revenue of 12.47B, resulting in a net margin of 15.1%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Merck & Co., Inc. reported a net income of 2.96B and revenue of 16.40B, resulting in a net margin of 18.1%.